COMBINED USE OF METHYLPHENIDATE AND MELATONIN FOR THE TREATMENT OF HYPERACTIVITY DISEASE WITH DEFICIT OF CARE.

摘要

Use of methylphenidate and at least one of: melatonin, melatonin analogue, or one or more pharmaceutically acceptable salts or esters thereof, in the preparation of a medicament for the treatment of ADHD in mammals, especially humans.